History
  • No items yet
midpage
Takeda Pharmaceutical Company v. Sun Pharma Global Fze
16-2325
Fed. Cir.
Apr 10, 2017
Check Treatment
Docket

TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS AMERICA, INC. v. SUN PHARMA GLOBAL FZE, SUN PHARMACEUTICAL INDUSTRIES, LTD.

2016-2325

United States Court of Appeals for the Federal Circuit

April 10, 2017

NOTE: This disposition is nonprecedential. Appeal from the United States District Court for the District of New Jersey in No. 3:14-cv-04616-MLC-TJB, Judge Mary L. Cooper.

JUDGMENT

ARLENE L. CHOW, Hogan Lovells US LLP, New York, NY, argued for plaintiffs-appellants. Also represented by ERIC J. LOBENFELD, THOMAS SCHMIDT.

MARK DAVID SCHUMAN, Carlson, Caspers, Vandenburgh, Lindquist & Schuman, P.A., Minneapolis, MN, argued for defendants-appellees. Also represented by SAMUEL T. LOCKNER, JONATHAN CARPENTER, CAROLINE MARSILI.

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (PROST, Chief Judge, NEWMAN and DYK, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

April 10, 2017

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court

Case Details

Case Name: Takeda Pharmaceutical Company v. Sun Pharma Global Fze
Court Name: Court of Appeals for the Federal Circuit
Date Published: Apr 10, 2017
Citation: 16-2325
Docket Number: 16-2325
Court Abbreviation: Fed. Cir.
AI-generated responses must be verified and are not legal advice.
Log In